Exosome-based cell therapy for diabetic foot ulcers: Present and prospect

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Diabetes Complications Research

Background:

• Diabetic foot ulcers (DFUs) are a severe complication of diabetes, leading to high morbidity, mortality, and healthcare costs.
• Current DFU therapies are often challenging and insufficient, necessitating novel therapeutic strategies.
• Cell-free therapies, particularly exosomes, are emerging as a promising avenue for DFU treatment.

Purpose of the Study:

• To review the current research on the role and mechanisms of exosomes in diabetic wound healing.
• To explore the therapeutic potential of exosomes derived from various cellular sources for DFUs.
• To discuss the challenges and future directions for clinical applications of exosome-based therapies.

Main Methods:

• Literature review of studies investigating exosome function in wound healing models, with a focus on diabetes.
• Analysis of exosome-mediated mechanisms including anti-inflammation, angiogenesis, cell proliferation, migration, and collagen deposition.
• Evaluation of membrane vesicles as exosome mimics for therapeutic applications.

Main Results:

• Exosomes exhibit multifaceted therapeutic effects beneficial for all stages of diabetic wound healing.
• Key functions include modulation of inflammatory responses, promotion of new blood vessel formation, and enhancement of tissue regeneration.
• Exosomes and their mimics demonstrate significant potential for improving DFU treatment outcomes.

Conclusions:

• Exosomes represent a potent cell-free therapeutic strategy for managing diabetic foot ulcers.
• Further research and clinical translation are needed to overcome challenges associated with exosome-based therapies.
• Exosome mimics offer a viable alternative for enhancing DFU healing and reducing patient burden.